Tenaya therapeutics to announce initial data from mypeak-1 phase 1b/2 clinical trial of tn-201 gene therapy for mybpc3-associated hypertrophic cardiomyopathy on tuesday, december 17, 2024

Company to host conference call on tuesday, december 17, at 8:00 a.m. et company to host conference call on tuesday, december 17, at 8:00 a.m. et

TNYA Ratings Summary

TNYA Quant Ranking